Cambridge Investment Research Advisors, Inc. Azenta, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$39.51 - $61.95 $527,418 - $826,970	13,349 Added 385.36%	16,813 $750,000
Q4 2022 Feb 08, 2023	BUY	$38.6 - $62.07 $133,710 - $215,010	3,464 New	3,464 $202,000
Q2 2022 Jul 13, 2022	SELL	$64.69 - $85.07 $329,854 - $433,771	-5,099 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$76.3 - $103.81 $218,065 - $296,688	2,858 Added 127.53%	5,099 $422,000
Q4 2021 Feb 03, 2022	BUY	$92.98 - $124.15 $208,368 - $278,220	2,241 New	2,241 $231,000
Q4 2018 Feb 05, 2019	SELL	$23.22 - $35.29 $262,920 - $399,588	-11,323 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$28.71 - $39.6 $325,083 - $448,390	11,323 New	11,323 $0

Others Institutions Holding AZTA

# of Institutions

336

Shares Held

51.4M

Call Options Held

237K

Put Options Held

302K

Black Rock Inc. New York, NY

4.81M
Shares

$207 Million
0.01% of portfolio
Politan Capital Management LP New York, NY

4.61M
Shares

$198 Million
14.96% of portfolio
Vanguard Group Inc Valley Forge, PA

4.52M
Shares

$194 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.03M
Shares

$130 Million
0.04% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

2.24M
Shares

$96.1 Million
0.27% of portfolio

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.22B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account